Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.

Schmitz F, Heit A, Dreher S, Eisenächer K, Mages J, Haas T, Krug A, Janssen KP, Kirschning CJ, Wagner H.
Eur J Immunol. 2008 Nov;38(11):2981-92.

The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mTOR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1beta. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1beta. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.

URL: http://www3.interscience.wiley.com/journal/121451650/abstract

Pub Med: http://www.ncbi.nlm.nih.gov/pubmed/18924132

created over 15 years ago (9 December 2009)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]